BackBlueprint Medicines Overview

Blueprint Medicines Minority Interest

Blueprint Medicines's minority interest is $0.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer average / median

Loading

Blueprint Medicines Minority Interest History

Loading

Blueprint Medicines vs. peers: Minority Interest Comparison

Loading

Blueprint Medicines Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Blueprint Medicines (BPMC) FAQ

Blueprint Medicines (BPMC) currently reports a minority interest of $0 as of March 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Blueprint Medicines's minority interest history and peer comparisons.

Blueprint Medicines's minority interest changed from $0 to $0 (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Blueprint Medicines reported $0 in minority interest as of March 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Blueprint Medicines, and consider following BPMC for alerts when major investors trade the stock.

Blueprint Medicines is classified in the Healthcare sector. On minority interest, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BPMC with unrelated industries.